Blockchain Registration Transaction Record

MediVera Compounding Pharmacy™ Expands into 18 States Across Five Regions in 2024

MediVera Compounding Pharmacy™ has expanded into 18 new states across five regions in 2024, offering personalized medicine options including semaglutide and tirzepatide. The company's growth reflects its dedication to changing lives with personalized medicine and meeting the increasing demand for compounded medications.

This expansion by MediVera Compounding Pharmacy™ matters because it demonstrates the company's commitment to providing personalized medicine services across the country. The increased geographical reach allows prescribers and patients in these 18 new states to access tailored compounded medications, reflecting the growing interest in personalized medicine options.